Stent-graft infection following endovascular repair of aortic diseases poses a challenging clinical problem, and the prognosis could be poor and lethal. There are two scenarios of stent-graft infection. First, the emergency endovascular repair of a rupture or pending-rupture mycotic aortic aneurysm. Stent-grafts are infected after implantation into the infection lesions. Staged drainage and long-term use of systemic antibiotics have been reported to be effective to control the stent-graft infection35. If the infection cannot be controlled, open surgery conversion is recommended to remove the stent graft and the whole infected lesion even though the procedure is complicated36. Second, there were studies reported that non-infected aortic diseases were treated by endovascular procedure, but the stent-graft got infected during the perioperative period or months even years after procedure37. The prognosis in this case is even worse, as the infection is often caused by multi-resistance bacteria.
So, if we can develop an antimicrobial endograft, it may be applied in two scenarios in clinic. First, in mycotic aortic aneurysms, if local antimicrobial shield can be established by preventing the infection of endograft with Ag-NPs-loaded membranes, there would be a chance to conduct staged transcutaneous drainage and systemic antibiotics. And in this way, the mycotic aortic aneurysms might be cured by endovascular repair. Second, for non-infected aortic diseases, some patients are at high risk of developing endograft infection, such as the patients with diabetes, Immunodeficiency diseases, long-term use of glucocorticoids, poor fitness, or innutrition, et al. They would suffer from endograft infection at any time after the procedure or in long-term follow-up38. The long-lasting of Ag-NPs is required to prevent the stent-graft infection. If Ag-NPs could exist in the affected area for a long time, it might prevent endograft infection in selected cases.
In this study, a drug-loaded vascular membrane with antibacterial function and sustained drug release function, called Ag-NPs-loaded membrane, was prepared by coaxial electrospinning technology. Drug-loaded nanofibers were constructed through electrospinning. Due to the drug-loaded membrane prepared by blend electrospinning can only attach the drugs to the surface of fibers, the drug will be quickly lost after blood erosion after implantation into the body, and the long-term antibacterial effect cannot be achieved. Coaxial electrospinning is a kind of electrospinning technique of preparing fibers with a core-shell structure39. Compared with traditional electrospinning, coaxial electrospinning can encapsulate drug in the core layer of fibers to avoid the rapid loss of drug due to blood erosion and has better performance in drug loading and slow release40. This technology has been widely used in the biomedical field41.
In the coaxial electrospinning process, the liquid supply ratio of core-shell solution directly affects the formation quality of nanofibers and the forming of core-shell structure. We set three groups of parameters, when the liquid supply ratio is 1:2, the distribution diameter of nanofibers in the membrane is the most uniform, and the core-shell structure is well formed, and the drug is well wrapped in the inner layer. Therefore, we chose the liquid supply ratio of 1:2 as the parameter for membrane preparation. In addition, the membrane covered on stent in human blood vessels would be subjected to pressure from blood flow; therefore, the mechanical properties of membranes are essential for tissue engineering applications42. With the addition of CS and PEO, the tensile strength of the membrane prepared by coaxial electrospinning reached 2.108 ± 0.158 MPa. Although the tensile strength of Ag-NPs-loaded membrane is lower than that of PCL membrane prepared by uniaxial electrospinning, Ag-NPs-loaded membrane can still meet the mechanical performance requirements of human arterial blood vessels.
Hydrophilicity is an important index to evaluate the potential biological properties of vascular stent membranes. The membrane with better surface hydrophilicity is conducive to cell adhesion and proliferation, but the hydrophilicity will also affect cell migration. Therefore, the surface hydrophilicity of the membrane should not be too good. Due to the good hydrophilicity of CS and PEO, their addition can improve the hydrophilicity of the membrane. The water contact angle of the Ag-NPs-loaded membranes was about 70.87 ± 3.928°, showing good hydrophilicity, but not too hydrophilic. The effectiveness of cell inoculation is one of the important factors to evaluate the biocompatibility of membrane. Cell adhesion test showed that Ag-NPs-loaded membrane was more conducive to cell adhesion and proliferation than PCL membrane. Meanwhile, nanoparticles that show antimicrobial activity, including Ag-NPs, especially in the case of high concentration will be toxic to human cell, and even harmful to human health43. The cytotoxicity of the Ag-NPs-loaded membrane was detected by CCK-8. The results showed that the addition of Ag-NPs had little toxicity to HUVECs, the Ag-NPs-loaded membrane showed good biocompatibility and safety.
How to maintain the long-term drug release function and long-term bacteriostatic effect of the membrane is an urgent problem to be solved in tissue engineering. At present, amoxicillin, vancomycin and cephalosporin are commonly used as antibacterial drugs. In this study, we chose Ag-NPs as the drug loaded on the membrane. Studies had found that Ag-NPs produce antibacterial effects by binding to and penetrating the bacterial cell wall, after entering the cell wall, Ag-NPs will cause structural changes, disrupt the biochemical processes of DNA, cell enzymes and respiratory systems, and lead to bacterial death44, 45. After killing bacteria, Ag-NPs will be free from bacteria to continue to produce antibacterial effects. When testing its antibacterial properties, we selected E. coli and S. aureus as the representatives of negative/positive bacteria. The results showed that when the addition of Ag-NPs reached 3 wt%, the antibacterial effect of the membrane was obvious, and the inhibition circle remained unchanged within 120 h. Due to the lack of longer observation, it could only be preliminarily inferred that the Ag-NPs-loaded membrane has long-term antibacterial function, which needs further verification in the future. In the release test of Ag-NPs, the release rate of Ag-NPs-loaded membrane prepared by coaxial electrospinning was much slower than that of the uniaxial electrospun membrane. The sustained drug release function of Ag-NPs-loaded membrane is attributed to the coaxial electrospinning, which encapsulates Ag-NPs in the inner layer of nanofibers. The sudden release phenomenon in the first 24 h may be due to the small amount of Ag-NPs were attached to the surface of nanofibers, which were quickly released into the PBS after washing46, 47, and the remaining Ag-NPs wrapped by nanofibers were slowly released48. However, the detection of the release of Ag-NPs-loaded membrane was only carried out in the PBS solution in vitro, and the detection cycle was only 196 h, which is not enough to prove that the Ag-NPs-loaded membrane has a long-term sustained release function after implantation in vivo, so further research is needed.
Because the porcine aorta has similarities with the human abdominal aorta in terms of morphology, physiology, and branch vessel distribution49, it is appropriate model for studying abdominal aortic aneurysms and evaluating the efficacy and safety of metal vascular stents with Ag-NPs-loaded membranes50. Results of HE staining of porcine aneurysm grafts showed that the pig implanted with stent covered with Ag-NPs-loaded membrane had a significant inflammatory reaction. It was proved that Ag-NPs-loaded membrane successfully released Ag-NPs into the aneurysm cavity and inhibited the bacteria. However, there was no obvious inflammatory cell infiltration in the pig implanted without covered stent, proving that the bacteria had a good living environment and were not affected. In addition, Gram staining results showed that bacteria were almost invisible on the aneurysm graft of pig implanted with stent covered with Ag-NPs-loaded membrane. On the contrary, a large number of aggregated bacteria were observed in the porcine aneurysm implanted without covered stent. Pathological findings are presented well and easy to learn. Finally, the results indicated that antibacterial effects and good biocompatibility were explored at the stents with Ag-NPs-loaded membranes.
Limitation:
The mechanical properties and thickness of the membrane should be further optimized, so that it not only can cover the existing covered stent, but also can realize the exclusion function of the artificial vascular membrane of the current stent-graft. Then it can be directly combined with nitinol stent skeleton. In this way, the profile of delivery system of this antibacterial stent-graft could be significantly reduced, so as to realize the delivery through peripheral arteries such as femoral artery. Moreover, the release behavior of Ag-NPs on the membrane can be optimized to make it controllable, such as PH, temperature or electromagnetic response, which would fulfill different antibacterial time-histories requirements in clinic.